These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21211379)

  • 1. [The urodynamic diagnosis of benign prostatic hyperplasia with coexisting overactive bladder].
    Chen Y; DU GH; Chen Z; Cai D; Zhang Q; Yuan XY; Zeng XY; Yang WM; Ye ZQ
    Zhonghua Wai Ke Za Zhi; 2010 Dec; 48(23):1767-70. PubMed ID: 21211379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity.
    Shahab N; Seki N; Takahashi R; Kajioka S; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2009; 28(8):953-8. PubMed ID: 19260093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of urodynamic findings and voiding habits in patients with concomitant benign prostatic hyperplasia and detrusor overactivity presenting with or without the symptom of urgency.
    Tong YC
    Urol Int; 2007; 78(3):219-25. PubMed ID: 17406130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pathophysiology underlying overactive bladder syndrome possibly due to benign prostatic hyperplasia].
    Akino H; Maegawa M; Nagase K; Tanaka I; Nakai M; Ishida Y; Oyama N; Miwa Y; Yokoyama O
    Hinyokika Kiyo; 2008 Jun; 54(6):449-52. PubMed ID: 18634444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical observation of holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasia and overactive bladder].
    Fu G; Liao LM; Hu Y; Li D; Ju YH; Wu J; Liang WL; Xiong ZS
    Zhonghua Wai Ke Za Zhi; 2010 Dec; 48(23):1774-7. PubMed ID: 21211381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urodynamic studies on benign prostatic hyperplasia combined with diabetes mellitus].
    Ding J; Qi L; Zu X; Shen P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 35(7):705-10. PubMed ID: 20693712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role of intravesical capsaicin instillation in benign prostatic hyperplasia with overactive bladder symptoms: the first reported study in the literature.
    Mahawong P; Chaiyaprasithi B; Soontrapa S; Tappayuthapijarn P
    J Med Assoc Thai; 2007 Sep; 90(9):1821-7. PubMed ID: 17957925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study.
    Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C
    BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of bladder function in benign prostatic hyperplasia].
    Murayama K; Katsumi T
    Hinyokika Kiyo; 1992 Oct; 38(10):1135-8. PubMed ID: 1282773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
    Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of overactive bladder in patients with benign prostatic hyperplasia in the Czech Republic.
    Hanuš T; Zámečník L; Doležal T; Karmazínová Z
    Urol Int; 2011; 86(4):407-13. PubMed ID: 21454947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role of intravesical capsaicin instillation in benign prostatic hyperplasia with overactive bladder symptoms: the first reported study in the literature.
    Mahawong P; Chaiyaprasithi B; Soontrapa S; Tappayuthapijarn P
    J Med Assoc Thai; 2007 Nov; 90(11):2301-9. PubMed ID: 18181311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of urodynamic study in benign prostatic hyperplasia].
    Wei Z; Zhou Z; Zheng S
    Zhonghua Wai Ke Za Zhi; 1995 Jan; 33(1):54-6. PubMed ID: 7539737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of posture and repetition on urodynamic parameters: A prospective randomized study.
    Jeon HJ; Choo MS; Oh SJ
    Investig Clin Urol; 2017 Jan; 58(1):34-41. PubMed ID: 28097266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
    Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
    J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urodynamic effects of solifenacin in untreated female patients with symptomatic overactive bladder.
    Tanaka Y; Masumori N; Tsukamoto T
    Int J Urol; 2010 Sep; 17(9):796-800. PubMed ID: 20649825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary prostaglandins E2 correlates to overactive bladder symptoms in patients with benign prostatic hyperplasia].
    Zhang YJ; Bai Q
    Zhonghua Nan Ke Xue; 2014 Mar; 20(3):244-8. PubMed ID: 24738462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urodynamic findings in female diabetic patients with and without overactive bladder symptoms.
    Ho CH; Tai HC; Yu HJ
    Neurourol Urodyn; 2010 Mar; 29(3):424-7. PubMed ID: 19283863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness and safety of naftopidil for benign prostatic hyperplasia patients with overactive bladder symptoms].
    Ge JP; Gong J; Ma HQ; Wei W; Shang XJ; Zhang ZY; Xu S; Wang D; Gao JP
    Zhonghua Nan Ke Xue; 2008 Oct; 14(10):927-30. PubMed ID: 19157107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-operative opening detrusor pressure is predictive of detrusor overactivity following TVT in patients with pre-operative mixed urinary incontinence.
    Panayi DC; Duckett J; Digesu GA; Camarata M; Basu M; Khullar V
    Neurourol Urodyn; 2009; 28(1):82-5. PubMed ID: 19089898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.